WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced its participation in Pathology Visions, taking place November 3-5, 2024 ...

STOCKHOLM - November 8, 2017-ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has added new members to its advisory board for DESUTO, a Eurostar ...

STOCKHOLM – August 26, 2021 - ContextVision, a medical technology software company specializing in image processing and decision support tools within digital pathology, today announces that the Board ...

SAN FRANCISCO, CA--(Marketwired - Oct 20, 2014) - Pathology Visions 2014 (Booth #103) -- Mikroscan Technologies, a pioneer in desktop whole-slide scanning systems for pathology, biology and research ...

The global computer vision in healthcare market is projected to expand at a compound annual growth rate (CAGR) of approximately 25% over the forecast period. This robust growth is driven by the ...

With a clinical version of PathAI‘s computer vision-based pathology detection service still at least one year from coming to market, the diagnostic technology developer has snagged $60 million in its ...

The big test for biomedical and security technology developer Vision Systems in the year ahead will be if it can pull off the transition from heavy investment in product development to ...

NEW YORK--(BUSINESS WIRE)--Paige, the global leader in AI-based diagnostic software in pathology, today announced a series of presentations at the Pathology Visions 2021 conference, taking place ...

Joe Lennerz, MD, PhD, Chief Scientific Officer at BostonGene, will discuss advancements in regulatory science within digital and computational pathology, emphasizing collaborative strategies to ...